Scientist profiles M-R
MMacDonald, Russell D.MacIntosh, Bradley
NNam, DianeNam, RobertNascimento, BartoNathens, AveryNevo, Ori
OO'Reilly, MeaghanOrser, Beverley
PPang, GeordiPapia, Giuseppe Paszat, LawrencePerry, James
RRabeneck, LindaRachlis, AnitaRakovitch, EileenRapoport, MarkRast, Jonathan P.Ravi, AnanthRazmjou, HelenRector, NeilRedelmeier, DonaldReis, MarcianoRezmovitz, JeremyRichter, Peggy Margaret AnneRizoli, SandroRobinson, LarryRoifman, IdanRose, LouiseRowlands, JohnRubenfeld, Gordon
Dr. JoAnne McLaurin
McLaurin is a senior scientist in the Hurvitz Brain Sciences Research Program at SRI. She studies the development of potential therapeutics to target protein-misfolding disorders such as Alzheimer’s disease. She aims to understand better the disease process, and how the brain starts to deteriorate and develop memory and cognitive deficits. Stemming from basic research on protein-lipid interactions, her lab developed a small molecule therapy called scyllo-inositol. The compound is being tested in patients to treat neuropsychiatric symptoms associated with mild to moderate Alzheimer’s disease. McLaurin is expanding her work to examine other neurodegenerative disorders such as amyotrophic lateral sclerosis, and Huntington’s and Parkinson’s diseases to prevent progression and improve quality of life for patients.